AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 FEB 11 - (NewsRx.com & NewsRx.net) -- Integrated BioPharma (INB) has acquired intellectual property developed by the Center for Molecular Biotechnology (CMB) of Fraunhofer USA, Inc.
The agreement covers exclusive rights to proprietary technology and intellectual property in the area of expression, engineering, testing, production, and validation of human therapeutic proteins in plants.
The Fraunhofer Center for Molecular Biotechnology has a suite of new technologies, including genetically engineered plant viruses for producing veterinary and human vaccines, therapeutic proteins, antibodies, and industrial enzymes in plants. INB, through its wholly owned subsidiary NuCycle Therapy, Inc., has an ongoing collaboration with Fraunhofer to produce generic drugs, and in particular therapeutic proteins using CMB's proprietary technology.
"This agreement creates a partnership that will ...